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Background-—Subclinical left ventricular (LV) dysfunction has been inconsistently associated with early cognitive impairment, and
mechanistic pathways have been poorly considered. We investigated the cross-sectional relationship between LV dysfunction and
structural/functional measures of the brain and explored the role of potential mechanisms.
Method and Results-—A total of 1338 individuals (696 years) from the Southall and Brent Revisited study underwent
echocardiography for systolic (tissue Doppler imaging peak systolic wave) and diastolic (left atrial diameter) assessment. Cognitive
function was assessed and total and hippocampal brain volumes were measured by magnetic resonance imaging. Global LV
function was assessed by circulating N-terminal pro–brain natriuretic peptide. The role of potential mechanistic pathways of
arterial stiffness, atherosclerosis, microvascular disease, and inﬂammation were explored. After adjusting for age, sex, and
ethnicity, lower systolic function was associated with lower total brain (betastandard error, 14.93.2 cm3; P<0.0001) and
hippocampal volumes (0.050.02 cm3, P=0.01). Reduced diastolic function was associated with poorer working memory
(0.210.07, P=0.004) and ﬂuency scores (0.180.08, P=0.02). Reduced global LV function was associated with smaller
hippocampal volume (0.100.03 cm3, P=0.004) and adverse visual memory (0.0760.03, P=0.02) and processing speed
(0.0630.02, P=0.006) scores. Separate adjustment for concomitant cardiovascular risk factors attenuated associations with
hippocampal volume and ﬂuency only. Further adjustment for the alternative pathways of microvascular disease or arterial
stiffness attenuated the relationship between global LV function and visual memory.
Conclusions-—In a community-based sample of older people, measures of LV function were associated with structural/functional
measures of the brain. These associations were not wholly explained by concomitant risk factors or potential mechanistic
pathways. ( J Am Heart Assoc. 2017;6:e004898. DOI: 10.1161/JAHA.116.004898.)
Key Words: arterial stiffness • brain imaging • brain volumes • cognitive function • cognitive impairment • left ventricular
dysfunction • left ventricular dysfunction • microvascular dysfunction
T here is an established link between heart failure (HF) andimpaired cognitive function, with the prevalence of mild
cognitive impairment in HF patients as high as 53%.1
Subclinical left ventricular (LV) dysfunction has also been
associated with early cognitive impairment; however, ﬁndings
are inconsistent. While some studies have shown associations
between impaired cognition and LV systolic dysfunction,2,3
one investigation found stronger relationships with LV dias-
tolic dysfunction.4
Volumetric brain analyses by cerebral magnetic resonance
imaging (MRI) have shown a close association between
reduced hippocampal volume and cognitive impairment.5,6
Yet, results from studies associating cardiac function with
cerebral MRI ﬁndings are conﬂicting, with grey matter loss in
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the hippocampal regions related to LV dysfunction in some
studies7 and not others.8,9
Inconsistencies in associations between LV dysfunction
and cognitive status may be explained by selection of study
populations, with some samples chosen according to disease
or risk status,4 as well as range of measurement of LV and
brain indices.2,4,8
Importantly, previous studies have failed to test whether
the LV function-cognition relationship is the result of con-
founding by other pathophysiological mechanisms, such as
arterial stiffness, microvascular damage, atherosclerosis, and
inﬂammation. These mechanisms are known to be adversely
associated both with LV function10,11 and cognition12,13; thus,
observed associations between LV function and cognition may
be confounded by “common causes.” Understanding these
pathways is essential to identifying cardiac targets that may
delay or prevent cognitive decline and dementia.
We aimed to combine comprehensive and sensitive
measures of global, systolic, and diastolic LV function, with
MRI and cognition data in a community-based, multiethnic
cross-sectional sample of older people, as well as investi-
gate explanatory mechanisms. We hypothesized that
adverse LV function would be associated with low brain
volumes and cognitive dysfunction. We additionally adjusted
for cardiometabolic risk factors and separately examined the
role of: (1) arterial stiffness, (2) atherosclerosis, (3)
microvascular disease, and (4) inﬂammation in accounting
for any observed associations between LV function and
cognitive measures.
Methods
Study Population
The SABRE (Southall And Brent REvisited) study is a tri-ethnic
population-based cohort consisting of white European (2346),
ﬁrst-generation migrant South Asian (1711), and African
Caribbean (801) men and women. Cohort details have been
previously described.14 In brief, men and women aged 40 to
69 years from the West London areas of Southall and Brent
were recruited from general practitioners’ lists and from
workers in local industries. Sampling was stratiﬁed by
ethnicity, sex, and age group. Exclusions included conditions
that would preclude informed consent or attendance at a local
clinic. The target sample was sent letter invitations from their
general practitioner. Positive respondents were contacted by
phone to discuss the study and sent participation information
sheets before attending local clinics for investigation.
Surviving participants were invited to attend the 20-year
follow-up investigation between 2008 and 2011. The study
was conducted at the Imperial Biomedical Research Centre,
London. The study was approved by St Mary’s Hospital
Research Ethics Committee (07/H0712/109) and all partic-
ipants provided written informed consent. The study adheres
to the principles of the Declaration of Helsinki and Title 45, US
Code of Federal Regulations, Part 46, Protection of Human
Subjects, Revised November 13, 2001, effective December
13, 2001.
Investigations
At the follow-up clinic, participants fasted and refrained from
alcohol, smoking, and caffeine for at least 12 hours before
attendance, omitting medication on the clinic morning.
Participants completed a questionnaire detailing sociodemo-
graphic characteristics (including years of education as a
measure of socioeconomic position), health behaviors, med-
ical history, and medication. Height, weight, and waist
circumference were measured as previously described.14
Waist-hip ratio was calculated. Seated brachial blood pressure
was measured after 10 minutes of rest using an Omron 705IT
(Omron Healthcare, Kyoto, Japan). An appropriately sized cuff
was placed on the left upper arm, 3 recordings were taken
2 minutes apart, and the second and third recordings were
averaged. Hypertension was deﬁned as use of blood pressure–
lowering medication from patient questionnaire and general
practitioners’ medical record review. We also included indi-
viduals who had a clinic systolic blood pressure >140 mm Hg
or diastolic blood pressure >90 mm Hg. Established diabetes
mellitus was deﬁned by medical records. Participants without
known diabetes mellitus underwent an oral glucose tolerance
test, and unrecognized diabetes mellitus was deﬁned accord-
ing to World Health Organization 1999 guidelines.15 Coronary
artery disease was deﬁned as a coronary event or revascular-
ization identiﬁed by hospital admissions and medical record
review and adjudicated by an independent committee. Stroke
diagnoses was based on predetermined criteria of symptoms,
duration of symptoms, and MRI or computed tomography
imaging from hospital admission, patient, or medical
records.16 HF and atrial ﬁbrillation were identiﬁed during
clinic visit and/or via medical records.
Cognitive function
Cognitive assessments were conducted by trained staff on the
morning of investigation to avoid fatigue. The battery
comprised tests previously validated for cross-cultural set-
tings.17,18 The following domains were derived by summing
standardized individual test scores: global/overall function
(Community Screening Instrument for Dementia [CSID] cog-
nitive assessment)19; verbal memory (immediate and delayed
verbal recall [CERAD 10-word]20), visual memory (picture
recognition); ﬂuency (animal naming21), processing speed
(color trail-making A and B22); and working memory (forward
and backward digit span23).
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Magnetic Resonance Imaging
Total and hippocampal brain volume. Cerebral MRI was
performed based on the Cardiovascular Health Study
protocol.24 This included sagittal T1-weighted and axial
T1-weighted, proton density, and T2-weighted images of
5-mm thickness with no gaps. For volumetric measures, 3-mm
axial ﬂuid-attenuated inversion recovery and coronal 1.5-mm
3-dimensional T1-weighted gradient echo images were also
obtained. A third of the scans were performed on a General
Electric Signa HDxt 1.5T scanner and the rest on a General
Electric Discovery MR750 3T scanner (GE Healthcare,
Waukesha, WI)
An automated segmentation protocol was used to quantify
total brain and hippocampal volume using FIRST in FSL 4.1.25
Total brain volume (TBV) was computed as the volume after
skull stripping of the T1-weighted image using BET26 in FSL
5.0. Hippocampal volumes were calculated as the sum of right
and left segmented volumes. Brain volumes and cognitive
function domains were standardized into z scores.
White matter hyperintensities. Assessment of white
matter hyperintensities was performed by one grader (meth-
ods have been previously described27). Severity of white
matter hyperintensities was scored on a 10-point scale
combining periventricular and subcortical foci. White matter
grades were grouped into the following categories: none for
grade 0, mild for grade 1, moderate for grade 2, and severe
for grades at least 3.
Echocardiography. Echocardiography was performed using a
Philips iE33 ultrasound machine (Philips, Amsterdam, The
Netherlands) with a 5.0 to 1.0 phased array transducer (S5-1),
as previously described.28,29 LV mass was calculated accord-
ing to American Society of Echocardiography guidelines and
indexed to height2.7. Left atrial diameter was measured using
2-dimensional echocardiography and indexed to height. LV
hypertrophy was classiﬁed according to American Society of
Echocardiography guidelines. Transmitral ﬂow velocity during
the early ﬁlling phase (E) and the late ﬁlling phase (A) were
acquired by pulsed Doppler and averaged from 3 consecutive
cycles. Tissue Doppler imaging was used in pulsed wave mode
to measure longitudinal tissue velocities. The sample volume
was placed at the mitral annulus of the lateral and septal LV
wall. Peak velocities during systole (Sa), early diastole (Ea),
and late diastole (Aa) were averaged from 3 consecutive
cycles and averaged. The ratio of the transmitral early and late
ﬁlling phases (E:A) and the ratio of early and late tissue
Doppler imaging peak velocities (Ea/Aa) were calculated as
measures of diastolic function. The ratio of early ﬁlling and
early myocardial velocity (E/Ea) was calculated as a
noninvasive index of LV ﬁlling pressure. Diastolic dysfunction
was classiﬁed according to American Society of Echocardio-
graphy guidelines.
Stroke Volume (SV) ¼ End-diastolic volume (EDV)
 End-systolic volume (ESV)
Ejection Fraction (EF) ¼ SV=EDV
Cardiac Output (CO) ¼ SV Heart Rate
Cardiac Index (CI) ¼ CO=BSA
Retinal photography. Retinal photography was performed
using a Zeiss FF450+ fundus camera (Oberkochen, Germany),
and 30° digital images of the disc (ETDRS Field 1), macula
(ETDRS Field 2), temporal to macular region (ETDRS Field 3),
and superior-temporal region (ETDRS Field 4) were captured
using an Allied Vision Tech Oscar 510C CCD (258891958
pixels; Singapore) following pupillary dilation with tropicamide
(1%) and phenylephrine (2.5%). Digital retinal photography was
performed on 1205 participants, and analyzable images were
obtained in 1185 individuals. Images were graded for
retinopathy and classiﬁed as none, mild, moderate, or
severe/proliferative according to the NHS Diabetic Eye
Screening Programme feature-based grading classiﬁcation
http://diabeticeye.screening.nhs.uk/gradingcriteria.
Blood and urine analysis. Serum N-terminal pro–brain
natriuretic peptide (NT-proBNP) was measured using an
Elecsys 2010 electrochemiluminescence analyzer (Roche
Diagnostics, Burgess Hill, UK) calibrated using the manufac-
turer’s reagents. A combination of serum creatinine and
cystatin C concentrations were used to calculate estimated
glomerular ﬁltration rate, measured using an automated
analyzer (c311; Roche Diagnostics, Burgess Hill, UK). Serum
interleukin-6 was measured using a multiplex electrochemi-
luminescence immunoassay (MSD, Rockville, MD). A spot
early-morning urine sample was measured for albumin and
creatinine and the albumin:creatinine ratio was calculated.
Statistical Analysis
Statistical analyses were performed using Stata version 13.0
(StatCorp, College Station, TX). Participant characteristics for
continuous data are reported as meanSD, or median
(interquartile range) for skewed data, and number (percentage)
for categorical data. Full echocardiography data are presented
in Table 1; however, 3 key LV measures were selected a priori
for analysis. For systolic function, the key measure was the
tissue Doppler imaging systolic wave (Sa), which was chosen
for its precision and sensitivity to early long-axis systolic
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dysfunction compared with ejection fraction.30 For diastolic
function, left atrial diameter indexed to height was chosen
because it provides a long-term indication of the effects of
chronically elevated ﬁlling pressure. NT-proBNP levels repre-
sented global dysfunction.31 With the exception of diastolic
dysfunction grade, all LV measures are presented as contin-
uous variables. Multivariable regression analyses assessed the
associations of markers of LV systolic, diastolic, and global
function with cognitive function scores and brain volume (total
and hippocampal). Sex and ethnicity interactions were tested
and were nonsigniﬁcant, therefore all data were pooled, with
sex and ethnicity adjustment in all models. Model 1 adjusted
Table 1. Characteristics of All Participants Who Underwent
Echocardiography
No. 1338
Men, No. (%) 1011 (76)
Ethnicity, No. (%)
White European 632 (47)
South Asian 488 (37)
African Caribbean 218 (16)
Age, y 69.66.1
Body mass index, kg/m2 27.44.5
Waist-hip ratio
Men 1.000.06
Women 0.920.08
Hypertension, No. (%) 890 (67)
Diabetes mellitus, No. (%) 409 (31)
Coronary artery disease, No. (%) 324 (24)
Stroke, No. (%) 77 (6)
Heart failure, No. (%) 38 (3)
Atrial fibrillation, No. (%) 92 (7)
Smoking, No. (%)
Never 757 (57)
Ever 491 (37)
Current 83 (6)
Systolic blood pressure, mm Hg 14018
Diastolic blood pressure, mm Hg 7710
Mean arterial pressure, mm Hg 9811
Education, y 11.83.3
MRI brain volumes, cm3
Hippocampal volume 7.41.0
Total brain volume 1426174
LV global function
NT-proBNP, pg/mL 85 (47, 170)
LV systolic function
Ejection fraction, % 61.69.5
Ejection fraction <55%, No. (%) 274 (21)
Cardiac index, L/min per m2 2.060.5
Sa, cm/s 7.51.4
LV diastolic function, cm/s
Mitral E 6417
E/Ea 9.43.1
E:A 0.860.25
E/Aa 6.42.2
Ea/Aa 0.70.2
Continued
Table 1. Continued
Normal diastolic function, No. (%) 77 (6)
Mild diastolic dysfunction, No. (%) 948 (76)
Moderate diastolic dysfunction, No. (%) 220 (18)
Severe diastolic dysfunction, No. (%) 1 (0)
LADI, cm/m 0.0240.003
LV structure
LVMI, g/m2.7 44.011.9
LVH, No. (%) 304 (23)
EDV, mL 93.723.2
Vascular and other measures
cfPWV, m/s 11.43.5
cIMT, mm 0.820.2
Microvascular disease
ACR 3.0316.8
eGFR, mg/mL 73.416.2
Retinopathy, No. (%)
None 741 (67)
Mild 335 (30)
Moderate/proliferative 35 (3)
WMH
Grade 0 23 (2)
Grade 1 438 (35)
Grade 2 381 (30)
Grade 3 416 (33)
IL-6, pg/mL 1.702.7
Data are expressed as meanSD or median (25th–75th percentile for skewed data) for
numerical data and number (percentage) for categorical data. A indicates mitral inﬂow
late wave; Aa, tissue Doppler imaging peak late diastolic wave; ACR, albumin:creatinine
ratio; cfPWV, carotid to femoral pulse wave velocity; cIMT, carotid intima-media
thickness; Ea, tissue Doppler imaging peak early diastolic wave; EDV, end-diastolic
volume; eGFR, estimated glomerular ﬁltration rate; IL-6, interleukin 6; LADI, left atrial
diameter indexed to height; LV, left ventricular; LVH, left ventricular hypertrophy; LVMI,
left ventricular mass indexed to height2.7; Mitral E, mitral inﬂow early wave; MRI,
magnetic resonance imaging; NT-proBNP, N-terminal pro–brain natriuretic peptide; Sa,
tissue Doppler imaging peak systolic wave; WMH, white matter hyperintensities.
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for age, sex, and ethnicity. Model 2 additionally adjusted for
concomitant cardiometabolic risk factors, diabetes mellitus,
hypertension, previous stroke, coronary artery disease, waist-
hip ratio, years of education, and smoking.
Potential mechanisms
The following mechanisms were separately added to model 2
to understand their possible role in associations between key
LV measures and cognitive function/brain volumes: (1)
arterial stiffness was assessed by carotid to femoral pulse
wave velocity using the Micro-Medical Pulse Trace system
(PT2000; Rochester, Kent, UK); (2) far wall left common
carotid intima-media thickness imaged using a Philips iE33
ultrasound machine with a 11-3 MHz linear transducer was
used as a measure of subclinical atherosclerosis; (3) a global
measure of microvascular disease was calculated as a
composite z score of estimated glomerular ﬁltration rate,
albumin:creatinine ratio, white matter hyperintensities, and
retinal photography grade (these were chosen because they
correlate with MRI-measured cerebral microvascular dis-
ease32); and (4) interleukin-6 was chosen as our principal
inﬂammatory biomarker; however, additional sensitivity anal-
yses were conducted using interleukin-1b, interferon-c, tumor
necrosis factor-a, C-reactive protein, and glycoprotein acetyls
as alternative inﬂammatory markers. These alternative
biomarkers in models did not substantially alter ﬁndings and
the respective models are therefore not shown. Signiﬁcance
was assigned at P<0.05.
Results
Of the 1438 participants who returned for follow-up investi-
gations, a total of 1338 had full echocardiography. Of those
who had echocardiography, 1215 individuals also had full
cognitive data, 1264 had TBV measures, and 1080 had
hippocampal brain volume measures. Figure 1 is a ﬂow
diagram showing sample sizes for our key measures.
Participant Characteristics
Participant characteristics are presented in Table 1. The
mean (SD) age of the sample was 696 years. A total of 76%
of participants were men, 47% were white European, 37%
were South Asian, and 16% were African Caribbean. Hyper-
tension was highly prevalent (67%), while 31% of patients had
diabetes mellitus, 24% had coronary artery disease, 6%
experienced a stroke, 7% had atrial ﬁbrillation, and 3% had
HF.
Associations Between Left Ventricular Function
and Brain Volumes
Associations between LV function and brain volumes are
presented in Table 2. After adjusting for age, sex, and
ethnicity (model 1), poorer LV systolic function was signiﬁ-
cantly associated with smaller TBV and hippocampal volume.
A 1-cm/s decrease in Sa was associated with a 1% smaller
Figure 1. Flow chart showing sample sizes for our key measures. *A total of 104 cognitive function
tests were excluded for reasons that may have affected cognitive assessment, eg, impaired hearing/
eyesight. MRI indicates magnetic resonance imaging.
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TBV (14.93.2 cm3, P<0.0001) and a 0.68% smaller hip-
pocampal volume (0.050.02 cm3, P=0.01). The association
with TBV remained unchanged after adjustment for car-
diometabolic disease, education, and smoking (model 2:
14.93.3 cm3, P<0.0001), while the association with hip-
pocampal volume was slightly attenuated (model 2:
0.040.02 cm3, P=0.07). A signiﬁcant association was also
observed between greater NT-proBNP and smaller hippocam-
pal volume. Per-unit increase of NT-proBNP was associated
with a 1.35% smaller hippocampal volume (0.100.03 cm3,
P=0.004). This association was reduced after multivariate
adjustment (0.070.04 cm3, P=0.06). Associations
between other LV measures and brain volumes are presented
in Table S1.
Associations Between Left Ventricular and
Cognitive Function
In Table 2, model 1, Sa was not signiﬁcantly associated with
any measure of cognitive function. An increase in left atrial
diameter indexed to height was adversely associated with
working memory (0.210.07, P=0.004) and ﬂuency
(0.180.08, P=0.02). The association with working memory
persisted after further adjustment for confounders (Table 2,
model 2; 0.190.08 [P=0.01]). Increased levels of NT-
proBNP were adversely associated with visual memory
(0.0760.03, P=0.02) and processing speed scores
(0.0630.02, P=0.006). Further adjustment for confounders
(model 2) did not signiﬁcantly alter these associations.
Associations between other LV measures and cognitive
function are presented in Table S1.
Sensitivity Analyses
Sensitivity analyses were performed to test the associations
between brain volumes and LV function adjusting for height.
In a separate analysis, patients with prior stroke, atrial
ﬁbrillation, and HF were excluded (n=177); all results were
unaltered (results not shown).
Potential Mechanisms
Arterial stiffness, atherosclerosis, microvascular disease,
and inﬂammation were separately added to model 2.
Separate adjustment for any of these measures did not
alter the signiﬁcant association between Sa and TBV
(Figure 2A), left atrial diameter indexed to height, and
working memory (Figure 2B), or NT-proBNP and processing
speed (Figure 2C). However, the association between NT-
proBNP and visual memory was attenuated by adjustment
for either arterial stiffness or microvascular disease
(Figure 2C).Ta
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Discussion
In a community-based, multiethnic sample, we found robust
relationships between global, systolic and diastolic LV
dysfunction, and functional and structural measures of the
brain. Microvascular disease and greater arterial stiffness
appeared to partly explain some of the relationships; however,
the residual link between LV dysfunction and brain measures
could suggest a direct inﬂuence of LV dysfunction on brain
structure and function.
Normal aging is often associated with cognitive decline and
reductions in brain volume;33 these processes are accelerated
in the presence of cardiovascular disease and its risk factors,
although distinguishing between age-related and disease-
related cognitive decline is very difﬁcult.34 The study objective
was to investigate brain structure and function in a
A
B
Figure 2. Bar charts showing the effect sizes in the relationships between total brain volume
(TBV), hippocampal volume, Community Screening Instrument for Dementia (CSID), verbal
memory, visual memory, working memory, ﬂuency, and processing speed with (A) systolic (Sa), (B)
diastolic (LADI), and (C) global (N-terminal pro–brain natriuretic peptide) function. To facilitate
comparison across brain volumes and cognitive tests, all of the results on the y-axis are displayed
as mean bstandard error (SE) change in standardized values (z scores). Model 1 was adjusted
for age, sex, and ethnicity. Model 2 was additionally adjusted for diabetes mellitus, hypertension,
previous stroke, coronary artery disease, waist to hip ratio, years of education, and smoking.
Possible mechanisms are investigated by adjusting for all of the above-mentioned risk factors
(model 2) plus further separate adjustment for: (1) arterial stiffness, (2) atherosclerosis, (3)
microvascular disease, and (4) inﬂammation. *P<0.05, **P<0.01.
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community sample, and although the majority of participants
would not have fulﬁlled criteria for dementia, the ﬁndings are
important for our understanding of the full spectrum of brain
impairment.
Relationship Between Left Ventricular Function
and Brain Volumes
We show a robust association between LV systolic function
and TBV, unexplained by concomitant risk factors or known
mechanistic pathways. A 1-cm/s decrease in Sa was associ-
ated with a 1% smaller TBV (14.93.2 cm3, P<0.0001), which
corresponds to the equivalent volume change observed with
normal aging over 3.1 years.35 This relationship is consistent
with existing literature.8,36 We expand on previous results by
showing an association with Sa, a more sensitive measure of
systolic function,37 and by investigating the role of alternative
pathways. Furthermore, while previous studies investigated
associations with LV systolic function, we additionally found no
association between TBV and LV diastolic function or levels of
NT-proBNP.
Although losses in regional brain volume associated with
dementia are poorly understood, hippocampal atrophy has
been found to be an important predictor of progression from
mild cognitive impairment to Alzheimer’s disease38 and is
closely linked with amnesic subtypes of mild cognitive
impairment.27 We found associations between measures of
systolic and global LV function and hippocampal volume,
consistent with ﬁndings of hippocampal atrophy among
patients with HF.7 A 1-unit decrease in systolic function was
associated with a 0.68% smaller hippocampal volume
(0.050.02 cm3, P=0.01), and a 1-unit decline in global
function was associated with a 1.35% smaller hippocampal
volume (0.100.03 cm3, P=0.004), which corresponds to
the equivalent volume change observed with normal aging
over 0.8 and 1.6 years, respectively.35 These associations
were reduced, however, by adjustment for concomitant risk
factors. Our lack of other volumetric brain measures prevents
us from contributing to the discussion of other regions’
relative importance in the relationship between cardiac and
cognitive function.
Relationship Between Left Ventricular Function
and Domains of Cognitive Function
We assessed global/overall cognitive function, as well as the
domains of verbal memory, visual memory, working memory,
ﬂuency, and processing speed, since various cognitive modal-
ities have previously been differentially associated with LV
function.2,4,8 While we show no signiﬁcant associations
between Sa and cognitive function, we observed strong
associations between LV diastolic function and working
memory and ﬂuency, and LV global function and visual memory
and processing speed. With the exception of diastolic function
and ﬂuency, these associations persisted after adjustment for
cardiovascular risk factors. The level of decline observed in
working memory and ﬂuency per 1-unit decline in diastolic
function corresponds to the equivalent decline observed with
normal aging over 4.3 and 21.2 years. The level of decline
observed in visual memory and processing speed per 1-unit
decline in global function corresponds to the equivalent decline
observed with normal aging over 1.6 and 1.4 years, respec-
tively.39 These results are in agreement with the Hoorn study,
which previously highlighted the important role of global and
C
Figure 2. Continued.
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diastolic LV function on cognitive function.4 In contrast to our
results, the previous study reported stronger associations with
the domains of attention and executive functioning, rather than
memory. To the best of our knowledge, we are the ﬁrst to report
an association between diastolic function andworkingmemory.
The lack of an association in the Hoorn study might be due to
the grouping of several different subdomains of memory.
Potential Mechanisms
Despite calls for more work,40,41 limited research has
investigated the pathways explaining the LV dysfunction-
cognition relationship. In this study, we examined alternative
mechanisms that might explain our observed relationships.42
We conservatively conceptualized them as confounding;
however, it is possible that they may also act on the causal
pathway between LV function and brain structure and
function. The attenuation of the relationship between global
LV function and visual memory following arterial stiffness or
microvascular disease adjustment indicates confounding,
likely due to the common inﬂuence of these confounders on
both LV and cognitive dysfunction.
The residual link between LV dysfunction and brain
measures after adjustment for these pathways could suggest
a direct inﬂuence of LV dysfunction on both brain structure and
function, most likely to involve impaired cerebral perfusion
under stressor conditions. Hypoperfusion, through various
mechanisms, has been proposed as a probable candidate for
structural and functional brain changes,34,43,44 most likely
through reduced cardiac output for systolic dysfunction.
Further research is required to clarify the causative role of
diastolic dysfunction; however, it has recently been associated
with the development and progression of white matter lesions,
relating to heightened risks of cognitive decline.
Study Strengths
This study builds on previous literature by examining a range
of sensitive measures of global, systolic, and diastolic LV
function, using rigorous laboratory controls and protocols. In
particular, Sa is a highly sensitive and accurate measure of
systolic LV function, superior to ejection fraction/stroke
index, which only capture disturbed function at a later
stage.30 We have expanded previous work by exploring the
mechanisms through which LV function might affect brain
structure/function and alternative competing pathways. Our
results from this community-based, multiethnic study of
subclinical LV dysfunction provide generalizability beyond
previous work in this area,2,4,8 which had studied predomi-
nantly white, high-risk populations. The prevalence of HF was
low in our sample (3%) and therefore the results are unlikely to
be driven by clinical-level dysfunction.
Study Limitations
Despite the study strengths, there are some limitations to
consider. Our cross-sectional data preclude conclusions
regarding the direction of underlying causal relationships and
we cannot rule out the possibility of reverse causality.
Confounding factors at one time point does not take into
account cumulative or past exposure andwe cannot account for
confounding due to factors that have not been measured. We
also acknowledge that multiple comparisons were made,
increasing the possibility of a false-positive ﬁnding. Further-
more, loss to follow-up means that the group may be subject to
attrition and survival bias; however, by deﬁnition, assessment of
later-life cardiovascular and cognitive function necessitates
survival into old age. As is common in health research,45
healthier and socioeconomically advantaged participants were
more likely to attend, leading to a possible underestimation of
themagnitude of the associations observed, given that the least
healthy participants were less likely to have chosen/been able
to participate or to have survived to follow-up.
Conclusions
We have shown an association between LV dysfunction and
functional and structural measures of the brain that is not fully
explained by concomitant risk factors or alternative mecha-
nistic pathways. Prospective longitudinal studies are required
to fully understand the nature of the relationship between LV
function and abnormal brain structure and function. The clinical
implications of reduced cognition among people with impaired
LV function are considerable. Many cognitive processes
including executive function, memory, and reasoning are
needed to successfully manage chronic disease medication
regimens and to maintain independence in older age.34
Identiﬁcation of cognitive risk factors that can be targeted for
early modiﬁcation are of considerable clinical signiﬁcance for
delaying and even preventing dementia in our aging population.
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Table S1. Associations between all left ventricle function variables and brain volumes and cognitive function 
 Total Brain volume (cm3) Hippocampal volume (cm3) 
 Model 1 Model 2 Model 1 Model 2 
   Coeff±SE p Coeff±SE p Coeff±SE p Coeff±SE p 
Systolic function  
        
EF (%)  -0.32±0.44 0.5 -0.41±0.46 0.4 0.002±0.003 0.4 0.0006±0.003 0.8 
CI (L/ml/m2) 22.7±7.7 0.004 24.3±7.9 0.003 0.051±0.05 0.2 0.069±0.05 0.2 
TDI Sa (cm/s) 14.9±3.2 <0.0001  14.9±3.3 <0.0001 0.050±0.02 0.01 0.037±0.02 0.07 
Diastolic function  
        
Mitral E (cm/s) 0.50±0.25 0.05 0.50±0.3 0.05 -0.002±0.002 0.2 -0.001±0.002 0.5 
E:Ea  -0.80±1.4 0.6 -0.27±1.5 0.9 -0.019±0.009 0.03 -0.010±0.01 0.3 
E:Aa  -0.40±1.9 0.8  -0.24±2.0 0.9 -0.018±0.01 0.1 -0.008±0.01 0.5 
Ea:Aa  -2.27±2.0 0.9 -8.65±20.4 0.7 -0.17±0.13 0.2 -0.16±0.13 0.2 
DD group  0.68±9.5 0.9 -5.14±9.6 0.6 0.026±0.06 0.7 0.024±0.06 0.7 
LADI (cm/m) -3.25±14 0.8 -0.51±15 0.97 -0.04±0.09 0.7 0.03±0.1 0.7 
Global function 
        
NT-proBNP (pgml) 1.18±5.2 0.8 1.61±5.6 0.8 -0.098±0.03 0.004 -0.067±0.04 0.06 
Structure   
        
LVMI (g/m2.7) 0.0007±0.4 0.98 0.18±0.4 0.6 -0.002±0.002 0.4 0.0003±0.003 0.9 
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  CSID (z-score) Verbal Memory (z-score) 
 Model 1 Model 2 Model 1 Model 2 
    Coeff±SE p   Coeff±SE p   Coeff±SE p   Coeff±SE p  
Systolic function  
        
EF (%)  0.0015±0.002 0.5 0.0009±0.002 0.7 -0.0001±0.002 0.9 -0.0020±0.002 0.4 
CI (L/ml/m2) -0.10±0.04 0.005 -0.088±0.04 0.01 -0.12±0.04 0.003 -0.11±0.04 0.004 
TDI Sa (cm/s) 0.003±0.01 0.8 0.009±0.01 0.6 0.023±0.02 0.1 0.022±0.02 0.1 
Diastolic function  
        
Mitral E (cm/s) 0.0008±0.001 0.5 -0.0016±0.001 0.2 -0.0033±0.001 0.008 -0.0022±0.001 0.08 
E:Ea  -0.003±0.006 0.6 0.0014±0.007 0.8 -0.020±0.007 0.003 -0.020±0.007 0.007 
E:Aa 0.0086±0.009 0.3 0.020±0.01 0.03 -0.022±0.009 0.03 -0.011±0.0.01 0.3 
Ea:Aa 0.13±0.1 0.2 0.20±0.1 0.03 0.043±0.1 0.7 0.061±0.1 0.5 
DD group  -0.013±0.45 0.8 -0.04±0.04 0.3 -0.019±0.05 0.7 -0.035±0.414 0.4 
LADI (cm/m) -0.023±0.07 0.7 -0.01±0.07 0.9 -0.09±0.07 0.2 -0.03±0.07 0.7 
Global function 
        
NT-proBNP (pgml) -0.0068±0.02 0.8 -0.0041±0.02 0.9 -0.045±0.03 0.07 -0.020±0.03 0.4 
Structure   
        
LVMI (g/m2.7) 0.0008±0.002 0.01 -0.0026±0.002 0.1 -0.0066±0.002 <0.0001 -0.005±0.002 0.006 
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  Visual Memory (z-score) Working Memory (z-score) 
 Model 1 Model 2 Model 1 Model 2 
    Coeff±SE p   Coeff±SE p   Coeff±SE p   Coeff±SE p  
Systolic function  
        
EF (%)  -0.0008±0.003 0.8 -0.0004±0.003 0.9 0.0032±0.002 0.2 0.0025±0.002 0.2 
CI (L/ml/m2) 0.075±0.05 0.1 0.077±0.05 0.1 -0.044±0.04 0.3 -0.027±0.04 0.5 
TDI Sa (cm/s) -0.0052±0.02 0.8 -0.0047±0.02 0.8 0.003±0.02 0.9 0.0009±0.02 0.96 
Diastolic function  
        
Mitral E (cm/s) 0.0002±0.002 0.9 0.00057±0.002 0.7 0.0022±0.001 0.1 0.0027±0.001 0.05 
E:Ea  -0.0013±0.09 0.9 -0.0005±0.01 0.96 0.0047±0.007 0.5 0.0080±0.008 0.3 
E:Aa 0.010±0.01 0.4 0.016±0.01 0.2 0.0085±0.01 0.4 0.020±0.01 0.06 
Ea:Aa 0.13±0.13 0.3 0.16±0.13 0.2 0.043±0.1 0.7 0.11±0.1 0.3 
DD group  -0.98±0.06 0.1 -0.10±0.06 0.1 0.065±0.05 0.2 0.029±0.05 0.5 
LADI (cm/m) 0.09±0.09 0.3 0.13±0.10 0.2 -0.21±0.07 0.004 -0.19±0.08 0.01 
Global function 
        
NT-proBNP (pgml) -0.076±0.03 0.02 -0.083±0.04 0.02 -0.033±0.03 0.2 -0.026±0.03 0.4 
Structure   
        
LVMI (g/m2.7) 0.0007±0.002 0.8 0.0019±0.003 0.5 -0.007±0.002 <0.0001 -0.0055±0.002 0.007 
 
 
 
 by guest on July 12, 2017
http://jaha.ahajournals.org/
D
ow
nloaded from
 
 Fluency (z-score) Processing Speed (z-score) 
 Model 1 Model 2 Model 1 Model 2 
    Coeff±SE p   Coeff±SE p   Coeff±SE p   Coeff±SE p  
Systolic function  
        
EF (%)  0.0049±0.003 0.05 0.0037±0.003 0.2 -0.0038±0.002 0.05 -0.0036±0.002 0.06 
CI (L/ml/m2) -0.019±0.04 0.7 -0.023±0.05 0.6 0.052±0.03 0.1 0.039±0.03 0.3 
TDI Sa (cm/s) 0.031±0.02 0.08 0.030±0.02 0.07 0.036±0.01 0.8 0.0015±0.01 0.9 
Diastolic function  
        
Mitral E (cm/s) -0.0013±0.001 0.4 -0.0002±0.001 0.9 -0.00027±0.001 0.8 -0.001±0.001 0.2 
E:Ea  -0.009±0.008 0.2 -0.006±0.008 0.5 0.0057±0.006 0.3 0.001±0.006 0.9 
E:Aa -0.086±0.01 0.4 -0.037±0.01 0.8 0.0006±0.008 0.9 -0.0086±0.009 0.3 
Ea:Aa -0.018±0.11 0.9 -0.082±0.12 0.8 -0.11±0.08 0.2 -0.16±0.09 0.06 
DD group  0.038±0.05 0.5 0.022±0.11 0.8 -0.030±0.04 0.5 -0.012±0.04 0.8 
LADI (cm/m) -0.18±0.08 0.02 -0.14±0.08 0.08 0.08±0.06 0.2 0.03±0.06 0.7 
Global function 
        
NT-proBNP (pgml) -0.043±0.03 0.1 -0.036±0.03 0.2 0.063±0.02 0.006 0.049±0.02 0.04 
Structure   
        
LVMI (g/m2.7) -0.0058±0.002 0.004 -0.0047±0.002 0.04 0.004±0.002 0.02 0.002±0.002 0.3 
Data are β± SE: Model 1: adjusted for age, sex and ethnicity. Model 2: additionally adjusted for diabetes, hypertension, previous stroke, 
coronary artery disease, waist-to-hip ratio, years of education and smoking. EF: ejection fraction; CI: cardiac index; Mitral E: Mitral 
inflow early wave, A: mitral inflow late wave. Sa: tissue Doppler imaging peak systolic wave; Ea: tissue Doppler imaging peak early 
diastolic wave, Aa: tissue Doppler imaging peak late diastolic wave. LADI: left atrium diameter indexed to height; NT-proBNP: N 
terminal prohormone brain natriuretic peptide; LVMI: left ventricle mass indexed to height2.7.  
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